EGFR and breast carcinoma: Further the research group65 describes that GABABR1e favors EGFR signaling by displacing phosphatase nonreceptor type 12 (PTPN12) to disrupt the interaction between EGFR and PTPN12, which in turn promotes the growth and invasion of breast cancer cells.